Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aptose Biosciences Inc (APTO)

  • Business News
  • Nov. 13, 2025, 22:00 UTC
  • 9
  • 0 comments

Aptose Reports Third Quarter 2025 Results

Market reaction Comment Full text

iRhythm Technologies Inc (IRTC)

  • Business News
  • Nov. 13, 2025, 22:00 UTC
  • 16
  • 1 comments

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

Market reaction Comment Full text

SAB Biotherapeutics (SABS)

  • Business News
  • Nov. 13, 2025, 22:00 UTC
  • 16
  • 1 comments

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 13, 2025, 21:46 UTC
  • 7
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

Zimmer Biomet Holdings Inc (ZBH)

  • Business News
  • Nov. 13, 2025, 21:41 UTC
  • 13
  • 1 comments

Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 13, 2025, 21:40 UTC
  • 5
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Nov. 13, 2025, 21:39 UTC
  • 17
  • 1 comments

Law Offices of Howard G. Smith Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action

Market reaction Comment Full text

VistaGen Therapeutics Inc. (VTGN)

  • Business News
  • Nov. 13, 2025, 21:30 UTC
  • 19
  • 1 comments

Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update

Market reaction Comment Full text

Senti Biosciences Inc. (SNTI)

  • Business News
  • Nov. 13, 2025, 21:30 UTC
  • 24
  • 1 comments

Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

Market reaction Comment Full text

Precision Optics Corporation Inc (POCI)

  • Business News
  • Nov. 13, 2025, 21:30 UTC
  • 15
  • 1 comments

Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results

Market reaction Comment Full text
  • Previous
  • 642
  • 643
  • 644
  • 645
  • 646
  • Next

Search

News categories

  • Technical Exchange News(10958)
  • Event(2424)
  • SEC News(192804)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125617)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin